IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 55 filers reported holding IKENA ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $33,218 | +162.0% | 20,132 | +125.5% | 0.00% | – |
| Q1 2024 | $12,678 | +28.8% | 8,928 | +78.7% | 0.00% | – |
| Q4 2023 | $9,840 | -38.8% | 4,995 | +34.5% | 0.00% | -100.0% |
| Q3 2023 | $16,077 | +167.6% | 3,713 | +305.3% | 0.00% | – |
| Q2 2023 | $6,008 | +46115.4% | 916 | -74.3% | 0.00% | – |
| Q1 2023 | $13 | -64.9% | 3,563 | -74.4% | 0.00% | -100.0% |
| Q4 2022 | $37 | -99.7% | 13,918 | +262.3% | 0.00% | – |
| Q3 2022 | $13,000 | -7.1% | 3,842 | +21.5% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 3,163 | +75.4% | 0.00% | – |
| Q1 2022 | $11,000 | -50.0% | 1,803 | +2.7% | 0.00% | – |
| Q4 2021 | $22,000 | +144.4% | 1,755 | +135.3% | 0.00% | – |
| Q3 2021 | $9,000 | -47.1% | 746 | -39.3% | 0.00% | – |
| Q2 2021 | $17,000 | – | 1,228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $3,711,053 | 2.75% |
| Blue Owl Capital Holdings LP | 4,091,118 | $6,750,345 | 1.88% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $8,279,994 | 0.87% |
| BML Capital Management, LLC | 585,114 | $965,438 | 0.69% |
| Acuitas Investments, LLC | 399,879 | $659,800 | 0.35% |
| Deuterium Capital Management, LLC | 80,578 | $132,954 | 0.22% |
| BVF INC/IL | 4,769,164 | $7,869,121 | 0.22% |
| Orbimed Advisors | 3,539,358 | $5,839,941 | 0.12% |
| NEA Management Company, LLC | 570,050 | $940,583 | 0.07% |
| Sofinnova Investments, Inc. | 382,616 | $631,316 | 0.03% |